Metropolitan Life Insurance CO Soma Logic, Inc. Transaction History

Metropolitan Life Insurance CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.76 - $2.83 $5,181 - $8,331	-2,944 Reduced 33.59%	5,821 $14,000
Q1 2023 May 15, 2023	SELL	$2.13 - $3.6 $1,384 - $2,340	-650 Reduced 6.9%	8,765 $22,000
Q4 2022 Jun 14, 2023	BUY	$2.05 - $3.47 $1,332 - $2,255	650 Added 7.42%	9,415 $23.6 Million
Q3 2022 Jun 14, 2023	BUY	$0.63 - $5.47 $409 - $3,555	650 Added 7.42%	9,415 $27.3 Million
Q2 2022 Jun 20, 2023	BUY	$4.27 - $8.26 $2,775 - $5,369	650 Added 7.42%	9,415 $42,000
Q2 2022 Aug 11, 2022	BUY	$4.27 - $8.26 $40,202 - $77,767	9,415 New	9,415 $43,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.